Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies: Phase IIa Clinical Study. Mascia M, Villano C, De Francesco V, Schips L, et al. Clin Nucl Med 2021 Apr 21. pii: 00003072-900000000-96076.

Read + Share

Amedeo Smart

Independent Medical Education

Mascia M, Villano C, De Francesco V, Schips L, et al. Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies: Phase IIa Clinical Study. Clin Nucl Med 2021 Apr 21. pii: 00003072-900000000-96076.
PMID: 33883484